Compare BOLD & BIRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BOLD | BIRD |
|---|---|---|
| Founded | 2018 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Apparel |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.7M | 25.4M |
| IPO Year | 2024 | 2021 |
| Metric | BOLD | BIRD |
|---|---|---|
| Price | $1.13 | $3.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $4.00 | ★ $11.00 |
| AVG Volume (30 Days) | 57.3K | ★ 66.7K |
| Earning Date | 06-22-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.47 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $189,757,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.96 | $2.45 |
| 52 Week High | $1.78 | $12.84 |
| Indicator | BOLD | BIRD |
|---|---|---|
| Relative Strength Index (RSI) | 46.09 | 53.23 |
| Support Level | $1.10 | $2.45 |
| Resistance Level | $1.19 | $3.36 |
| Average True Range (ATR) | 0.03 | 0.31 |
| MACD | -0.00 | 0.08 |
| Stochastic Oscillator | 37.50 | 60.14 |
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.
Allbirds Inc is a lifestyle brand that innovates with naturally derived materials to make footwear and apparel products in a better way, while treading lighter on the planet. Its primary source of revenue is from sales of shoes and apparel products. The majority of the revenue is derived from United States.